Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Sales (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Return on Sales data on record, last reported at 0.02% in Q4 2025.

  • For Q4 2025, Return on Sales fell 4.0% year-over-year to 0.02%; the TTM value through Oct 2025 reached 0.04%, up 5.0%, while the annual FY2025 figure was 0.08%, 23.0% up from the prior year.
  • Return on Sales reached 0.02% in Q4 2025 per CSBR's latest filing, up from 0.03% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.26% in Q1 2025 and bottomed at 0.21% in Q1 2024.
  • Average Return on Sales over 5 years is 0.03%, with a median of 0.02% recorded in 2022.
  • Peak YoY movement for Return on Sales: dropped -25bps in 2023, then surged 47bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.02% in 2021, then plummeted by -105bps to 0.0% in 2022, then plummeted by -15872bps to 0.18% in 2023, then surged by 130bps to 0.05% in 2024, then tumbled by -71bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.02% in Q4 2025, 0.03% in Q3 2025, and 0.15% in Q2 2025.